Fabio
107 lines
6.0 KiB
Markdown
107 lines
6.0 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies, limit."
|
||
description: "Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit. Decreases the cap on the cost-sharing payment that a covered person is required to pay for a covered prescription insulin drug from $50 to $35 for a 30-day supply of the prescription insulin drug and provides such cap is an aggregate cap that applies in situations where the covered person is prescribed more than one insulin drug. The bill also establishes such an aggregate cap of $35 for a 30-day supply of diabetes equipment and supplies."
|
||
jurisdiction: "us/states/va"
|
||
legislature: "Virginia General Assembly"
|
||
session: "2026"
|
||
identifier: "HB 1214"
|
||
citation: "Virginia HB 1214 (2026)"
|
||
classification: ["bill"]
|
||
subjects: []
|
||
status: "enacted"
|
||
primary_sponsors: ["Karrie K. Delaney"]
|
||
version_count: 4
|
||
action_count: 33
|
||
vote_count: 10
|
||
first_action: "2026-01-14"
|
||
last_action: "2026-04-13"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/48114462-fb3b-4b9d-a78b-76599da56e0a"
|
||
source_url: "https://lis.virginia.gov/bill-details/20261/HB1214"
|
||
source_hash: "fc5b5aa3750c73f311df85c345c3151ad4f9561bab4dfb1d0108ed3859c8b322"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-va"]
|
||
---
|
||
|
||
# Virginia HB 1214 (2026) — Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies, limit.
|
||
|
||
Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies; limit. Decreases the cap on the cost-sharing payment that a covered person is required to pay for a covered prescription insulin drug from $50 to $35 for a 30-day supply of the prescription insulin drug and provides such cap is an aggregate cap that applies in situations where the covered person is prescribed more than one insulin drug. The bill also establishes such an aggregate cap of $35 for a 30-day supply of diabetes equipment and supplies.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Introduced** (filed) — [source](https://lis.blob.core.windows.net/files/1087788.PDF)
|
||
2. **Commerce and Labor Amendment** (committee substitute) — [source](https://lis.blob.core.windows.net/files/1202087.HTML)
|
||
3. **Senate Amendment** (committee substitute) — [source](https://lis.blob.core.windows.net/files/1205988.HTML)
|
||
4. **Enrolled** (enrolled) — [source](https://lis.blob.core.windows.net/files/1213516.PDF)
|
||
|
||
## Votes
|
||
|
||
- Reported from Commerce and Labor with amendment — **15–0** (pass) · upper
|
||
- Constitutional reading dispensed (on 2nd reading) — **37–0** (pass) · upper
|
||
- Passage R — **39–0** (pass) · upper
|
||
- Reconsider R — **40–0** (pass) · upper
|
||
- H VOTE: — **97–0** (pass) · lower
|
||
- Reported from Labor and Commerce — **22–0** (pass) · lower
|
||
- Passage R — **40–0** (pass) · upper
|
||
- Subcommittee recommends reporting — **9–0** (pass) · lower
|
||
- H VOTE: — **96–0** (pass) · lower
|
||
- H VOTE: — **98–0** (pass) · lower
|
||
|
||
## Sponsors
|
||
|
||
- Karrie K. Delaney — primary (person)
|
||
- Adele Y. McClure — cosponsor (person)
|
||
- Elizabeth B. Bennett-Parker — cosponsor (person)
|
||
- Kathy K.L. Tran — cosponsor (person)
|
||
- Marcia S. "Cia" Price — cosponsor (person)
|
||
- Rozia A. Henson, Jr. — cosponsor (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2026-01-14** Prefiled and ordered printed; Offered 01-14-2026 26101381D `filing, introduction`
|
||
- **2026-01-14** Referred to Committee on Labor and Commerce `referral-committee`
|
||
- **2026-01-27** Assigned HCL sub: Subcommittee #1 `referral-committee`
|
||
- **2026-02-03** Subcommittee recommends reporting (9-Y 0-N)
|
||
- **2026-02-05** Reported from Labor and Commerce (22-Y 0-N) `committee-passage`
|
||
- **2026-02-09** Read first time `reading-1`
|
||
- **2026-02-10** Read second time and engrossed `reading-2`
|
||
- **2026-02-11** Read third time and passed House (96-Y 0-N 0-A) `passage, reading-3`
|
||
- **2026-02-11** Reconsideration of passage agreed to by House
|
||
- **2026-02-11** Passed House (98-Y 0-N 0-A) `passage`
|
||
- **2026-02-12** Constitutional reading dispensed (on 1st reading)
|
||
- **2026-02-12** Referred to Committee on Commerce and Labor `referral-committee`
|
||
- **2026-02-17** Fiscal Impact Statement from State Corporation Commission (HB1214)
|
||
- **2026-03-09** Senate committee offered
|
||
- **2026-03-09** Reported from Commerce and Labor with amendment (15-Y 0-N) `committee-passage`
|
||
- **2026-03-10** Rules suspended
|
||
- **2026-03-10** Constitutional reading dispensed (on 2nd reading) (37-Y 0-N 0-A)
|
||
- **2026-03-10** Passed by for the day (Voice Vote)
|
||
- **2026-03-11** Read third time `reading-3`
|
||
- **2026-03-11** Commerce and Labor Amendment agreed to `amendment-passage`
|
||
- **2026-03-11** Engrossed by Senate as amended
|
||
- **2026-03-11** Passed Senate with amendment Block Vote (39-Y 0-N 0-A) `passage`
|
||
- **2026-03-11** Reconsideration of Senate passage agreed to by Senate Block Vote (40-Y 0-N 0-A)
|
||
- **2026-03-11** Passed Senate with amendment Block Vote (40-Y 0-N 0-A) `passage`
|
||
- **2026-03-12** Senate amendment agreed to by House (97-Y 0-N 0-A) `amendment-passage`
|
||
- **2026-03-30** Enrolled `enrolled`
|
||
- **2026-03-30** Bill text as passed House and Senate (HB1214ER) `passage`
|
||
- **2026-03-30** Signed by President `passage`
|
||
- **2026-03-31** Signed by Speaker `passage`
|
||
- **2026-03-31** Enrolled Bill communicated to Governor on March 31, 2026 `enrolled, executive-receipt`
|
||
- **2026-03-31** Governor's Action Deadline 11:59 p.m., April 13, 2026 `executive-receipt`
|
||
- **2026-04-13** Fiscal Impact Statement from State Corporation Commission (HB1214)
|
||
- **2026-04-13** Approved by Governor-Chapter 752 (effective 7/1/2026) `executive-signature`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/48114462-fb3b-4b9d-a78b-76599da56e0a`. Confidence: reported (aggregated from official Virginia legislature records).
|
||
|